1. Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial.

Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial.

M F Rahman, A K Nandi, S Kabir, M Kamal, M S Basher, L A Banu

Randomized Controlled Trial

60 participants

2015

7 citations

Key insights related to Protopic from this study:


  • What is this paper about?

    This paper compares two treatments for atopic dermatitis in children: tacrolimus ointment (0.03%) and hydrocortisone acetate (1%). The study aimed to evaluate which treatment was more effective and safer for children with atopic dermatitis.

  • How did the authors study this?

    The researchers conducted a randomized controlled trial with 60 patients. Patients were randomly split into two groups - one group received tacrolimus 0.03% twice daily, while the other received 1% hydrocortisone acetate for three weeks. They measured the effectiveness using the Eczema Area and Severity Index (EASI) score at the start and after three weeks of treatment.

  • What populations did the authors study?

    The study included children aged 2 to 10 years who had atopic dermatitis for at least one year. All participants met the Hanifin-Rajka criteria for atopic dermatitis diagnosis.

  • What did the authors find?

    Tacrolimus showed significantly better results than hydrocortisone. The tacrolimus group's EASI score decreased by 56.07%, while the hydrocortisone group's score only decreased by 27.16%. The final EASI scores were 4.86 for the tacrolimus group and 7.97 for the hydrocortisone group, showing a statistically significant difference.

  • What conclusions can we draw?

    The authors concluded that tacrolimus ointment (0.03%) is both effective and safe as a non-steroid treatment option for children with atopic dermatitis. It performed better than hydrocortisone in reducing the severity and extent of atopic dermatitis.

Did this article interest you?

As a member of the Lemma Health community, you'll stay up to date with research, hear about new products, and get exclusive access to discounts.

Group of men

Ready for better skin health?

At Lemma Health, we provide evidence-based skin care. Access dermatologists in all 50 states. Appointments available within 3 days. Receive your medications delivered. Get ongoing 24/7/365 support. Coordinate your care across specialties.

	show_careplan_button=
	user_careplan_id=
	user_authenticated=
	current_path=/research_study/topical_tacrolimus_versus_hydrocortisone_on_atopic_dermatitis_in_paediatric_patients_a_randomized_controlled_trial
	session_key=384opcsku3mr88hz9add9ayeg39tb4jo